コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
2 ture >38.8 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
3 ture >38.3 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
4 ions (P = 0.01), myositis (P = 0.02), and an erythrocyte sedimentation rate >40 mm/hour (P < 0.001) w
5 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
6 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
7 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
8 isease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR) was >/=3.2.
9 ips, or proximal aspects of the thighs), and erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
10 ck, shoulders, or hip girdle regions; and an erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
11 e age <65 years (OR = 10.647, P = 0.023) and erythrocyte sedimentation rate (ESR) >30 (OR = 6.414, P
12 variate analysis, age younger than 60 years, erythrocyte sedimentation rate (ESR) 20 mm/h or less, an
15 There is a positive correlation between the erythrocyte sedimentation rate (ESR) and large bowel upt
16 ents were assessed for correlations with the erythrocyte sedimentation rate (ESR) and platelet count.
17 riate analysis for EFS are stage of disease, erythrocyte sedimentation rate (ESR) at diagnosis, liver
18 of the respondents reported using either the erythrocyte sedimentation rate (ESR) or C-reactive prote
19 ), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at ba
20 th, the Health Assessment Questionnaire, and erythrocyte sedimentation rate (ESR) were used to develo
21 nderness, 3) physician global assessment, 4) erythrocyte sedimentation rate (ESR), 5) functional disa
24 s were calculated to estimate effect of age, erythrocyte sedimentation rate (ESR), and C-reactive pro
25 effect of acupuncture on morning stiffness, erythrocyte sedimentation rate (ESR), and C-reactive pro
26 a, hematuria, low hemoglobin level, elevated erythrocyte sedimentation rate (ESR), and presence of an
28 ere obtained periodically for measurement of erythrocyte sedimentation rate (ESR), C-reactive protein
29 nd rheumatoid factor-negative polyarthritis, erythrocyte sedimentation rate (ESR), C-reactive protein
30 fasting insulin, glucose, and lipid levels, erythrocyte sedimentation rate (ESR), C-reactive protein
31 at every visit included determination of the erythrocyte sedimentation rate (ESR), grip strength, pai
32 lesterol, triglycerides, C-reactive protein, erythrocyte sedimentation rate (ESR), hemoglobin, total
35 rythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation
40 tor (RF) positivity (93% versus 84%), higher erythrocyte sedimentation rate (ESR; 45 versus 36 mm/hr)
41 CI) 0.03-0.35, P < 0.0005]), as was a higher erythrocyte sedimentation rate (HR 0.80 [95% CI 0.67-0.9
42 smoking (OR 1.02, P = 0.04) and an elevated erythrocyte sedimentation rate (OR 1.02, P = 0.05) were
43 phocytosis (OR, 1.84; P = 0.0002), increased erythrocyte sedimentation rate (OR, 6.5; P = 0.0005), de
44 .039), low serum C4 (P = 0.046), an elevated erythrocyte sedimentation rate (P = 0.006), and abnormal
45 -glycoprotein concentration (p = 0.012), and erythrocyte sedimentation rate (p = 0.01); concentration
46 creases in albumin (P<.001) and decreases in erythrocyte sedimentation rate (P<.05), interleukin-6 (P
47 ated patients had greater mean reductions in erythrocyte sedimentation rate (p=0.009) and a two-fold
48 italization (P=0.05) and, at week 1, a lower erythrocyte sedimentation rate (P=0.02) and a tendency t
49 nt 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation rate 25.1 mm/hour) despite tre
50 ints, Larsen radiographic score 20 versus 3, erythrocyte sedimentation rate 33 mm/hour versus 20, and
51 6 months (mean tender joint count 28.2, mean erythrocyte sedimentation rate 46.5 mm/hour) were random
52 ctivity (disease activity score in 28 joints-erythrocyte sedimentation rate [DAS28-ESR] >/= 3.2 [rang
53 [LDA] according to Disease Activity Score 28-erythrocyte sedimentation rate [DAS28-ESR] </=3.2 or DAS
54 correlated with untreated disease activity (erythrocyte sedimentation rate [ESR]) (r = 0.5, P = 0.00
55 hysician's and patient's global assessments, erythrocyte sedimentation rate [ESR], and morning stiffn
56 atory markers (white blood cell [WBC] count, erythrocyte sedimentation rate [ESR], C-reactive protein
57 enderness, swelling, and deformity, nodules, erythrocyte sedimentation rate [ESR], C-reactive protein
58 onnaire), and serum markers of inflammation (erythrocyte sedimentation rate [ESR], high-sensitivity C
59 rity (rheumatoid factor [RF] seropositivity, erythrocyte sedimentation rate [ESR], joint swelling, ra
63 ned the relation between leukocyte count and erythrocyte sedimentation rate and diabetes incidence us
64 related with biomarkers of disease activity (erythrocyte sedimentation rate and double-stranded DNA c
65 serum albumin; MR was associated with higher erythrocyte sedimentation rate and lower albumin at all
67 cular dysfunction was associated with higher erythrocyte sedimentation rate and, at diagnosis only, l
70 demonstrated that a model which included the erythrocyte sedimentation rate at baseline (P = 0.005) a
71 ients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.
75 f 5.29 mg to 0.34 mg per deciliter), and the erythrocyte sedimentation rate decreased at month 3 (all
77 osteomyelitis may have an increase in their erythrocyte sedimentation rate during the first 2 weeks
78 ps with regard to abnormal elevations of the erythrocyte sedimentation rate following initial remissi
79 of amyloid A and C-reactive protein, and the erythrocyte sedimentation rate from baseline to month 3
81 naire Disability Scale, global severity, and erythrocyte sedimentation rate had a 3-6 times increased
85 evated peripheral white blood cell count and erythrocyte sedimentation rate may herald an infection o
86 of tocilizumab, the C-reactive protein level/erythrocyte sedimentation rate normalized, while placebo
87 usted hazard ratios for participants with an erythrocyte sedimentation rate of > or = 26 mm/hour comp
88 6 mm/hour compared with participants with an erythrocyte sedimentation rate of < or = 5 mm/hour were
89 f 8.5 IU/mL (normal range, 0-13.9 IU/mL), an erythrocyte sedimentation rate of 2 mm/hr (normal range,
90 ormal value, <10 mg/L [95.2 nmol/L]), and an erythrocyte sedimentation rate of 35 mm per hour (normal
91 el of less than 5 mg/L (47.6 nmol/L), and an erythrocyte sedimentation rate of 41 mm/h (0-15 mm/h).
93 th the inflammatory variant have an elevated erythrocyte sedimentation rate or abnormalities of other
94 , even without immediate availability of the erythrocyte sedimentation rate or the C-reactive protein
95 o had higher baseline C-reactive protein and erythrocyte sedimentation rate than the persistent CP gr
97 he most frequent presenting symptom, and the erythrocyte sedimentation rate was elevated in 98% of ca
99 lower physical QOL during followup, whereas erythrocyte sedimentation rate was most strongly associa
100 and C-reactive protein (CRP), as well as the erythrocyte sedimentation rate were measured serially.
102 ed by disease duration, 5% by the Westergren erythrocyte sedimentation rate, 14% by articular signs a
103 acute-phase reactants (C-reactive protein), erythrocyte sedimentation rate, and bone metabolism mark
104 ng hormone level, autoimmune antibody level, erythrocyte sedimentation rate, and C-reactive protein l
105 me) and disease activity (total joint count, erythrocyte sedimentation rate, and C-reactive protein)
106 uality of life, enthesitis, chest expansion, erythrocyte sedimentation rate, and C-reactive protein,
108 plained, statistically, by pain, depression, erythrocyte sedimentation rate, and disease duration.
109 mation markers C-reactive protein (CRP), the erythrocyte sedimentation rate, and interleukin-6 (IL-6)
111 ated with a reduction in C-reactive protein, erythrocyte sedimentation rate, and pericardial LGE in t
112 ectively), and lower white blood cell count, erythrocyte sedimentation rate, and platelet count (all
113 l sites, lactate dehydrogenase (LDH) levels, erythrocyte sedimentation rate, and platelet count did n
114 ndspread, lung involvement, muscle weakness, erythrocyte sedimentation rate, and platelet count.
115 gher anti-double-stranded DNA (dsDNA) titer, erythrocyte sedimentation rate, and SLE Disease Activity
116 seline and week 4 in the tender joint count, erythrocyte sedimentation rate, and urinary excretion of
117 k factors (ie, age, clinical stage, elevated erythrocyte sedimentation rate, B symptoms, large medias
118 ), joint swelling, joint pain or tenderness, erythrocyte sedimentation rate, C-reactive protein level
119 f the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-reactive protein, tube
121 (anemia, thrombocytopenia leukocytosis, high erythrocyte sedimentation rate, elevated levels of C-rea
122 tional diagnostic tests include blood tests (erythrocyte sedimentation rate, ESR; C-reactive protein,
123 ious infection, corticosteroid use, elevated erythrocyte sedimentation rate, extraarticular manifesta
124 on, and basic blood tests, which include the erythrocyte sedimentation rate, hemoglobin, white count,
125 greater physical function limitation, higher erythrocyte sedimentation rate, higher joint count sever
126 ngoing inflammation as indicated by elevated erythrocyte sedimentation rate, hypocomplementemia, and/
127 cts were noted in individual ACR components, erythrocyte sedimentation rate, onset of ACR20 response,
128 ficant improvement in 3 of 5 core variables (erythrocyte sedimentation rate, physician's global asses
129 4) levels were significantly reduced, as was erythrocyte sedimentation rate, possibly as a result of
130 orrelated with the C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor level,
131 disease duration, C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, nodul
132 interval 1.18-12.59], P=0.026) alongside the erythrocyte sedimentation rate, triglyceride level, pred
142 eumatologist ranked ACR 20, radiography, and erythrocyte sedimentation rate/c-reactive protein as the
143 ne kinase, thyroid-stimulating hormones, and erythrocyte sedimentation rate; all analyses were perfor
145 ures [3 patient and 3 assessor measures plus erythrocyte sedimentation rate]); 3) patient-only (media
149 nts who experienced complications had higher erythrocyte sedimentation rates (P<0.001) and C-reactive
150 articipants, the use of drugs was noted, and erythrocyte sedimentation rates and serum levels of high
151 eline levels of C-reactive protein and lower erythrocyte sedimentation rates compared with patients d
152 joint counts, C-reactive protein levels, and erythrocyte sedimentation rates had fallen significantly
153 those for the C-reactive protein levels and erythrocyte sedimentation rates in the same patients.
154 erythrocytes may contribute to the elevated erythrocyte sedimentation rates observed in inflammatory
157 d significantly increased neutrophil counts, erythrocyte sedimentation rates, and C-reactive protein,
158 mplete blood cell counts, metabolic factors, erythrocyte sedimentation rates, and levels of C-reactiv
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。